These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12942682)

  • 1. Can structured treatment interruptions (STIs) be used as a strategy to decrease total drug requirements and toxicity in HIV infection?
    Walmsley S; Loutfy M
    J Int Assoc Physicians AIDS Care (Chic); 2002; 1(3):95-103. PubMed ID: 12942682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structured treatment interruption in patients infected with HIV: a new approach to therapy.
    Gulick RM
    Drugs; 2002; 62(2):245-53. PubMed ID: 11817971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults.
    Pai NP; Tulsky JP; Lawrence J; Colford JM; Reingold AL
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005482. PubMed ID: 16235406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The concept of structured treatment interruptions in the management of patients with human immunodeficiency virus (HIV) disease: where are we currently?
    Idemyor V
    HIV Clin Trials; 2003; 4(2):79-83. PubMed ID: 12671774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics and evolution of HIV-1 during structured treatment interruptions.
    Frost SD
    AIDS Rev; 2002; 4(3):119-27. PubMed ID: 12416446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment interruptions in HIV-infected subjects.
    Bongiovanni M; Casana M; Tincati C; d'Arminio Monforte A
    J Antimicrob Chemother; 2006 Sep; 58(3):502-5. PubMed ID: 16816398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to decrease viral load rebound, and prevent loss of CD4 and onset of resistance during structured treatment interruptions.
    Foli A; Maserati R; Barasolo G; Castelli F; Tomasoni L; Migliorino M; Maggiolo F; Pan A; Paolucci S; Scudeller L; Tinelli C; D'Aquila R; Lisziewicz J; Lori F
    Antivir Ther; 2004 Feb; 9(1):123-32. PubMed ID: 15040544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structured treatment interruptions in HIV/AIDS therapy.
    Lisziewicz J; Lori F
    Microbes Infect; 2002 Feb; 4(2):207-14. PubMed ID: 11880054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structured treatment interruptions for the management of HIV infection.
    Lori F; Lisziewicz J
    JAMA; 2001 Dec; 286(23):2981-7. PubMed ID: 11743839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    Ann Intern Med; 2002 Sep; 137(5 Pt 2):381-433. PubMed ID: 12617573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting differential responses to structured treatment interruptions during HAART.
    Bajaria SH; Webb G; Kirschner DE
    Bull Math Biol; 2004 Sep; 66(5):1093-118. PubMed ID: 15294419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of HIV with drug resistance after CD4 cell count-guided structured treatment interruptions in patients treated with highly active antiretroviral therapy after dual-nucleoside analogue treatment.
    Nuesch R; Ananworanich J; Sirivichayakul S; Ubolyam S; Siangphoe U; Hill A; Cooper D; Lange J; Phanuphak P; Ruxrungtham K
    Clin Infect Dis; 2005 Mar; 40(5):728-34. PubMed ID: 15714420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.
    Oxenius A; Price DA; Günthard HF; Dawson SJ; Fagard C; Perrin L; Fischer M; Weber R; Plana M; García F; Hirschel B; McLean A; Phillips RE
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13747-52. PubMed ID: 12370434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parameters.
    Dybul M; Chun TW; Yoder C; Hidalgo B; Belson M; Hertogs K; Larder B; Dewar RL; Fox CH; Hallahan CW; Justement JS; Migueles SA; Metcalf JA; Davey RT; Daucher M; Pandya P; Baseler M; Ward DJ; Fauci AS
    Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15161-6. PubMed ID: 11734634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What are STIs and what are the goals of STIs?
    Proj Inf Perspect; 2004 Jan; (37):16-8. PubMed ID: 15119285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of minor populations of human immunodeficiency virus type 1 carrying the M184V and L90M mutations in subjects undergoing structured treatment interruptions.
    Metzner KJ; Bonhoeffer S; Fischer M; Karanicolas R; Allers K; Joos B; Weber R; Hirschel B; Kostrikis LG; Günthard HF;
    J Infect Dis; 2003 Nov; 188(10):1433-43. PubMed ID: 14624368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structured treatment interruptions following immediate initiation of HAART in eight patients with acute HIV-1 seroconversion.
    Vogel M; Lichterfeld M; Kaufmann DE; Mui SK; Altfeld M; Voigt E; Ahlenstiel G; Kupfer B; Walker B; Spengler U; Rockstroh JK
    Eur J Med Res; 2006 Jul; 11(7):273-8. PubMed ID: 16899420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computer simulation of structured treatment interruption for HIV infection.
    Ferreira J; Hernandez-Vargas EA; Middleton RH
    Comput Methods Programs Biomed; 2011 Nov; 104(2):50-61. PubMed ID: 21899913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.